SF3B1 and myelodysplastic syndrome: Early studies performed by second-generation sequencing showed a large number of aberrant selective splicing events in MDS, with somatic mutations in spliceosomal genes present in approximately half of MDS patients (21), with SF3B1 occurring most frequently.SF3B1 splicing factor mutations are thought to contribute to oncogenic transformation, but the underlying mechanisms remain incompletely understood.